TYSABRI®
TYSABRI® (Natalizumab) is a prescription medicine used to treat adults with relapsing forms of Multiple Sclerosis.
TYSABRI® is manufactured by Biogen.
Administration and Dosage:
Administration of TYSABRI® is by intravenous infusion every 4 weeks.
Common Side Effects:
The more common side effects of TYSABRI® include herpes infections, liver damage, allergic reactions, weakened immune system, and low platelet counts.
More information:
Please read the full Prescribing Information and Medication Guide for TYSABRI® and discuss any questions you have with your doctor.
Indication:
TYSABRI® is indicated to treat:
Multiple Sclerosis
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!
Check our Privacy Practice